J
J. Henes
Publications - 8
Citations - 4
J. Henes is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 8 publications receiving 4 citations.
Papers
More filters
Journal ArticleDOI
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium.
Otavio Cabral-Marques,Guido Moll,Rusan Catar,Beate Preuß,Lukas Bankamp,Ann-Christin Pecher,J. Henes,Reinhild Klein,A. S. Kamalanathan,Reza Akbarzadeh,Wieke M. van Oostveen,Bettina Hohberger,Matthias Endres,Bryan Koolmoes,Nivine E. W. Levarht,Rudmer Johannes Postma,Vincent van Duinen,Anton Jan van Zonneveld,Jeska K de Vries-Bouwstra,Cynthia M. Fehres,Florian Tran,Fernando Yuri Nery do Vale,Kamilla Batista da Silva Souza,Igor S. Filgueiras,Lena F. Schimke,Gabriela Crispim Baiocchi,Gustavo Cabral de Miranda,Dennyson Leandro Mathias da Fonseca,Paula Paccielli Freire,Alexander Hackel,Hanna Grasshoff,Anja Stähle,Antje Müller,Ralf Dechend,Xinhua Yu,J. Petersen,Franziska Sotzny,Thomas P. Sakmar,Hans D. Ochs,K Schulze-Forster,Harald Heidecke,Carmen Scheibenbogen,Yehuda Shoenfeld,Gabriela Riemekasten +43 more
TL;DR: The authors in this paper summarized and discussed the relevant findings and concepts presented in the biennial International Meeting on autoantibodies targeting GPCRs (the 4th Symposium), held in Lübeck, Germany, 15-16 September 2022.
Journal ArticleDOI
CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome.
Ann-Christin Pecher,Reinhild Klein,Rebekka Schairer,Katrin Lutz,Daniel Atar,Christian Seitz,A. Stanger,Christiane Braun,Marina Schmidt,Antje Bornemann,Christoph Faul,Wolfgang Bethge,J. Henes,Claudia Lengerke +13 more
TL;DR: In this paper , a patient with antisynthetase syndrome with progressive myositis and interstitial lung disease refractory to available therapies (including rituximab and azathioprine), who was treated with CD19-targeting CAR T cells in June 2022 at University Hospital Tübingen, Germany, with the last follow-up in February 2023.
Journal ArticleDOI
Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases
Rebecca Hasseli,Jutta G Richter,Bimba F. Hoyer,Hanns-Martin Lorenz,Alexander Pfeil,Anne C. Regierer,T Schmeiser,Anja Strangfeld,Reinhard E. Voll,Andreas Krause,A Grässler,P. Saar,Andreas Kapelle,Marina Backhaus,Norbert Blank,J. Henes,S. Osiek,Guido Hoese,Jan Brandt-Jürgens,Christof Specker,Ulf Müller-Ladner,Hendrik Schulze-Koops +21 more
TL;DR: In this paper , the clinical profile of SARS-CoV-2 breakthrough infections in at least double-vaccinated patients with inflammatory rheumatic diseases (IRDs) was analyzed.
Journal ArticleDOI
Unauthorized change of immunosuppressants by patients with rheumatic diseases in the COVID-19 pandemic: a cross-sectional analysis of a patient survey
TL;DR: In this paper , the authors analyzed the patients' fear of COVID-19 and unauthorized change of immunosuppressive medication in consequence of their fear and found that high fear levels seem to be associated with comorbidity burden.
Journal ArticleDOI
Pos0381 factors associated with pregnancy-related concerns in women with inflammatory rheumatic diseases – an analysis of a nationwide pregnancy cohort
Yvette Meissner,Britta Eickhoff,C Glaser,J. Henes,J. Richter,Susanna Spaethling-Mestekemper,Christof Specker,Rebecca Fischer-Betz,Anja Strangfeld +8 more
TL;DR: The German registry Rhekiss is a nationwide, multicentre, web-based longitudinal cohort study, which was initiated in 2015 to investigate pregnancies and related issues in women with various inflammatory rheumatic diseases as mentioned in this paper .